Human Cancer Biology High-Resolution Array CGH and Gene Expression Pro fi ling of Alveolar Soft Part Sarcoma
暂无分享,去创建一个
M. Loda | G. Dranoff | S. Pyne | A. Ligon | R. Sompallae | G. Nielsen | E. Stack | R. Flavin | S. Selvarajah | E. Chen | Saumyadipta Pyne
[1] C. Leslie,et al. Combining integrated genomics and functional genomics to dissect the biology of a cancer‐associated, aberrant transcription factor, the ASPSCR1–TFE3 fusion oncoprotein , 2013, The Journal of pathology.
[2] P. Komminoth,et al. Pathology and Genetics of Tumours of Soft Tissue and Bone , 2013 .
[3] An-Qin Zhang,et al. Screening of significantly hypermethylated genes in breast cancer using microarray-based methylated-CpG island recovery assay and identification of their expression levels. , 2012, International journal of oncology.
[4] Wei Liu,et al. Quantitative assessment of gene methylation and their impact on clinical outcome in gastric cancer. , 2012, Clinica chimica acta; international journal of clinical chemistry.
[5] P. Mukeňsnabl,et al. Clinical significance of hypermethylation status in NSCLC: evaluation of a 30-gene panel in patients with advanced disease. , 2011, Anticancer research.
[6] P. V. van Diest,et al. Frequent promoter hypermethylation of BRCA2, CDH13, MSH6, PAX5, PAX6 and WT1 in ductal carcinoma in situ and invasive breast cancer , 2011, The Journal of pathology.
[7] Z. Ling,et al. Possible role of Pax-6 in promoting breast cancer cell proliferation and tumorigenesis. , 2011, BMB reports.
[8] Jürgen Hoffmann,et al. Interleukin‐6 promotes tumorigenesis by altering DNA methylation in oral cancer cells , 2011, International journal of cancer.
[9] F. Algaba,et al. Evaluation of the methylation status of tumour suppressor genes for predicting bacillus Calmette-Guérin response in patients with T1G3 high-risk bladder tumours. , 2011, European urology.
[10] J. Rubenstein,et al. Lhx6 and Lhx8 Coordinately Induce Neuronal Expression of Shh that Controls the Generation of Interneuron Progenitors , 2011, Neuron.
[11] Ying Jin,et al. Pax6 is a human neuroectoderm cell fate determinant. , 2010, Cell stem cell.
[12] J. Rubenstein,et al. The Level of the Transcription Factor Pax6 Is Essential for Controlling the Balance between Neural Stem Cell Self-Renewal and Neurogenesis , 2009, PLoS genetics.
[13] T. Izumi,et al. Molecular analyses of cell origin and detection of circulating tumor cells in the peripheral blood in alveolar soft part sarcoma. , 2009, Cancer genetics and cytogenetics.
[14] R. Shoemaker,et al. BMC Cancer BioMed Central Research article Gene expression profiling of alveolar soft-part sarcoma (ASPS) , 2009 .
[15] A. Lazar,et al. Angiogenesis-Promoting Gene Patterns in Alveolar Soft Part Sarcoma , 2007, Clinical Cancer Research.
[16] P. Schirmacher,et al. Detection of the ASPSCR1–TFE3 gene fusion in paraffin‐embedded alveolar soft part sarcomas , 2007, Histopathology.
[17] A. Folpe,et al. Alveolar soft-part sarcoma: a review and update , 2006, Journal of Clinical Pathology.
[18] L. Guillou,et al. Alveolar soft-part sarcoma of the uterine corpus: Histological, immunocytochemical and ultrastructural study of a case , 2005, Virchows Archiv A.
[19] G. Semenza. Targeting HIF-1 for cancer therapy , 2003, Nature Reviews Cancer.
[20] M. Ladanyi,et al. Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents. , 2001, The American journal of pathology.
[21] Alfons Meindl,et al. The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25 , 2001, Oncogene.
[22] H. Miki,et al. RT-PCR Suggests Human Skeletal Muscle Origin of Alveolar Soft-Part Sarcoma , 2000, Oncology.
[23] R. Zarbo,et al. Immunohistochemical profile of myogenin and MyoD1 does not support skeletal muscle lineage in alveolar soft part sarcoma. , 1999, Archives of pathology & laboratory medicine.
[24] S. Knuutila,et al. DNA copy number changes in alveolar soft part sarcoma: a comparative genomic hybridization study. , 1998, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[25] A. Gown,et al. Does alveolar soft-part sarcoma exhibit skeletal muscle differentiation? An immunocytochemical and biochemical study of myogenic regulatory protein expression. , 1996, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[26] H. Correa,et al. Trisomy 8 in alveolar soft part sarcoma. , 1995, Cancer genetics and cytogenetics.
[27] V. Eusebi,et al. Alveolar soft-part sarcoma: a new type of rhabdomyosarcoma? , 1994, Seminars in diagnostic pathology.
[28] Mark L. Greenberg,et al. Molecular genetic, cytogenetic, and immunohistochemical characterization of alveolar soft‐part sarcoma: Implications for cell of origin , 1992, Cancer.
[29] P. Houghton,et al. MyoD1 protein expression in alveolar soft part sarcoma as confirmatory evidence of its skeletal muscle nature. , 1991, The American journal of surgical pathology.
[30] T. Hasegawa,et al. Cytoskeletal properties of alveolar soft part sarcoma. , 1990, Human pathology.
[31] H. Evans. Alveolar soft‐part sarcoma. A study of 13 typical examples and one with a histologically atypical component , 1985, Cancer.